Amiodarone, commonly known as amiodarone hydrochloride, is used to treat cardiac arrhythmias. Due to the different metabolism and drug sensitivity of each patient, the therapeutic effect of this drug varies, and the drug should be standardized in accordance with medical advice.
Amiodarone hydrochloride is an antiarrhythmic drug that can block sodium channels, reduce myocardial oxygen consumption, and has a direct dilating effect on coronary arteries and peripheral blood vessels. Clinically, it is mainly used for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation, but also for paroxysmal supraventricular tachycardia and atrial fibrillation that are ineffective with other medications, or for the control of ventricular rate in the case of persistent atrial fibrillation and atrial flutter.
Adverse reactions such as rash, erythema, hypothyroidism, tachycardia, and constipation may occur in some patients during the use of amiodarone hydrochloride, and prolonged administration of large amounts of the drug may cause respiratory distress. In addition, amiodarone hydrochloride is contraindicated in patients with severe hypotension, circulatory failure, sinus bradycardia, or sinus block without placement of an artificial pacemaker.
Each person has a different sensitivity to drugs, the same disease, the patient’s physical condition is different, different stages of the disease, the therapeutic effect of the drug is also different. It is recommended that patients should seek timely medical treatment when discomfort occurs, and the doctor should choose the most appropriate and effective medication for treatment according to the specific condition.